DNA copy number changes in young gastric cancer patients with special reference to chromosome 19

A. Varis, B. Van Rees, M. Weterman, A. Ristimäki, J. Offerhaus, S. Knuutila

Research output: Contribution to journalArticlepeer-review

26 Scopus citations


Only a few cytogenetic and genetic studies have been performed in gastric cancer patients in young age groups. In the present study we used the comparative genomic hybridisation (CGH) method to characterise frequent DNA copy number changes in 22 gastric cancer patients of 45 years or younger and three gastric cancer cell lines established from patients younger than 45 years. Analysis of DNA copy number changes revealed frequent DNA copy number increases at chromosomes 17q (52%), 19q (68%) and 20q (64%). To confirm the CGH results and to characterise the amplicon region on the most frequently amplified chromosome, chromosome 19, we carried out fluorescence in situ hybridisation (FISH) analysis and Southern blot analysis. Fluorescence in situ hybridisation with the bacterial artificial chromosome (BAC) clone mapped to 19q12 indicated a copy number increase in all eight tumour specimens studied. Southern blot analysis of six tumour specimens and three tumour cell lines, with five probes mapped to the 19q12 - 13.2 region, suggested cyclin E to be one of the candidate target genes in the 19q region for gastric cancer tumorigenesis. Cyclin E protein overexpression was verified in tumours with amplification on chromosome 19. Further studies are required to investigate the biological and clinical significance of 19q amplicon and cyclin E upregulation in gastric cancer of young patients.

Original languageEnglish (US)
Pages (from-to)1914-1919
Number of pages6
JournalBritish Journal of Cancer
Issue number12
StatePublished - Jun 16 2003
Externally publishedYes


  • 19q
  • Comparative genomic hybridisation
  • Cyclin E
  • Gastric cancer

ASJC Scopus subject areas

  • Cancer Research
  • Oncology


Dive into the research topics of 'DNA copy number changes in young gastric cancer patients with special reference to chromosome 19'. Together they form a unique fingerprint.

Cite this